DANIPHARM A/S: Financial statements 2014
CVR: 12335040
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
DANIPHARM A/S (CVR 12335040) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 90,097,985 and a net result of DKK 8,871,761 compared with DKK 232,276 the year before. That is an increase of 6.2% compared with the year before. The profit margin was 9.8%. Equity in the 2014 report amounted to DKK 15,295,843. The solvency ratio was 50.9%. The company had 23 employees in the financial year.
- Revenue
- DKK 90,097,985
- Gross Profit
- DKK 30,941,757
- Profit/Loss
- DKK 8,871,761
- Equity
- DKK 15,295,843
- Total Assets
- DKK 30,046,119
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 90.1 mio. | 30.9 mio. | 8.9 mio. | 15.3 mio. | 23 |
| 2013 | 84.8 mio. | 21.9 mio. | 232 t. | 6.4 mio. | 21 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout DANIPHARM A/S
DANIPHARM A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1988. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Peter Rørvig. The board consists of Niels Ulrik Heine (chair), Helle Rørvig and Peter Rørvig. The company is owned by H&P Rørvig Holding A/S. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 37,586,751 and a net result of DKK 13,717,304 compared with DKK 5,113,647 the year before. Equity in the 2025 report amounted to DKK 60,280,949.